Evidence map›Paper›PMID 27365090›Full record

ArticleInternational journal of clinical pharmacy2016

Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.

Mohammad Ismail, Farmanullah Khan, Sidra Noor, Iqbal Haider, Inam-Ul Haq, Zahid Ali, Zahir Shah, Mohsin Hassam

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Comparing Important and Well-documented Potential Drug-Drug Interactions between Emergency, Medical, and Surgical ICUs of a Respiratory Referral Center.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mohammad IsmailDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan. ismailrph@upesh.edu.pk.
Farmanullah KhanDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Sidra NoorDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Iqbal HaiderMedical Unit, Khyber Teaching Hospital, Peshawar, Pakistan.
Inam-Ul HaqDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Zahid AliDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Zahir ShahDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Mohsin HassamDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
University of Peshawar · PKKhyber Teaching Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Patients admitted to intensive care unit (ICU) present with severe and life-threatening illnesses. Most of them suffer from various comorbidities. They usually receive complex pharmacotherapy with large number of medicines which increase the risk of drug-drug interactions (DDIs). Objective The present report aimed to investigate prevalence and levels of potential DDIs (pDDIs) in medical ICU. Methods Medications profiles of 416 patients were checked for pDDIs using Micromedex Drug-Reax(®). Prevalence, levels of severity and levels of documentation were reported. Results Of total 416 patients, 310 were exposed to pDDIs (overall prevalence = 74.5 %). Likewise, a prevalence rate of 13.9 % was recorded for contraindicated pDDIs, 52.2 % for major pDDI and 58.4 % for moderate pDDI. This study reported 740 interacting drug pairs that were presented in total 1686 pDDIs. Of 1686 pDDIs, 4.3 % were of contraindicated severity, 33.8 % of major severity and 49.6 % of moderate severity, whereas 45.5 % were of fair scientific evidence and 41.4 % of good scientific evidence. Conclusion In this study, pDDIs were found highly prevalent in ICU patients at a rate of 74.5 %. Most of the pDDIs had moderate severity; however, substantial number of interactions (38.1 %) had major and contraindicated severity.

Indexed as

Drug InteractionsDrug MonitoringFemaleHospitalizationHumansIntensive Care UnitsMalePakistanRisk FactorsTertiary Care CentersAdverse drug eventClinical pharmacyDrug interactionDrug-related problemIntensive care unitPakistan-Potential drug–drug interaction

Identifiers

PMID27365090
OpenAlexW2460758719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.